{"abstract":"The National Human Genome Research Institute is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the United States, European and Canadian Applications listed in the SUPPLEMENTARY INFORMATION section of this notice to AveXis, Inc., located in Bannockburn, Illinois, USA.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2020/07/16/2020-15342.html","cfr_references":[],"citation":"85 FR 43246","comment_url":null,"comments_close_on":"2020-07-31","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the National Human Genome Research Institute's Technology Transfer Office on or before July 31, 2020 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2020-15342","effective_on":null,"end_page":43246,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2020/07/16/2020-15342.xml","html_url":"https://www.federalregister.gov/documents/2020/07/16/2020-15342/prospective-grant-of-an-exclusive-patent-license-gene-therapy-for-treatment-or-prevention-of","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2020-15342?publication_date=2020-07-16","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2020-07-16/2020-15342/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":193,"last_updated":"2026-10-24 18:15:05 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2020-07-16/pdf/2020-15342.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2020-15342.pdf?1594817130","publication_date":"2020-07-16","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2020/07/16/2020-15342.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T03:53:50Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":43246,"subtype":null,"title":"Prospective Grant of an Exclusive Patent License: Gene Therapy for Treatment or Prevention of Niemann-Pick Disease Type C1, Subject to Existing Three Non-Exclusive Licenses","toc_doc":"Gene Therapy for Treatment or Prevention of Niemann-Pick Disease Type C1, Subject to Existing Three Non-Exclusive Licenses","toc_subject":"Prospective Grant of Exclusive Patent License:\n","topics":[],"type":"Notice","volume":85}